The E13 category carries the same instructional note directing coders to use additional code Z79.4 when the patient is on insulin
And no one has yet, I think, proven that GLP-1 has really important effects on these indications, but we are testing it in 4,000 people with Alzheimer's disease
Those products are not the same as a studied pharmaceutical product
Next-Generation Phenotyping: Introducing PhecodeX for Enhanced Discovery Research in Medical Phenomics
No Pain, No Gain The main ETFs in the weight-loss drug segment are the Tema Cardiovascular and Metabolic ETF (HRTS), the Roundhill GLP-1 and Weight Loss ETF (OZEM) and Amplify Weight Loss Drug & Treatment ETF (THNR)
If a specific GLP-1 drug, such as Ozempic, is causing intolerable side effects, speak with your healthcare provider about trying another antidiabetic or weight loss medication with the same active ingredient, such as Wegovy (weight loss drug), or another medication from the same class of GLP-1 medications, such as Mounjaro, which may be better tolerated